SEC Company Response from Apollo Endosurgery, Inc. (CIK 0001251769) — May 17, 2021
Apollo Endosurgery, Inc. (CIK 0001251769)
Date: May 17, 2021 · CIK: 0001251769 · Accession: 0001251769-21-000066
AI Filing Summary & Sentiment
File numbers found in text: 333-255786
Show Raw Text
CORRESP 1 filename1.htm Document May 17, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3720 Washington, D.C. 20549 RE: Apollo Endosurgery, Inc. Registration Statement on Form S-3 File No. 333-255786 Ladies and Gentlemen: Apollo Endosurgery, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on May 19, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of John McKenna and Mark Weeks of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059, or in his absence, Mark Weeks at (650) 843-5011. Very truly yours, APOLLO ENDOSURGERY, INC. By: /s/ Stefanie Cavanaugh Name: Stefanie Cavanaugh Title: Chief Financial Officer cc: Charles McKhann, Apollo Endosurgery, Inc. Brian Szymczak, Apollo Endosurgery, Inc. Mark B. Weeks, Cooley LLP John T. McKenna, Cooley LLP Milson C. Yu, Cooley LLP